Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CardioClasp Inc.

This article was originally published in Start Up

Executive Summary

David Melvin, MD, a cardiac transplant surgeon who started and built the heart transplant program at the University Hospital, Cincinnati, took a sabbatical in 1991 to research and invent devices for congestive heart failure. His efforts resulted in several patented devices, among them the CardioClasp. CardioClasp is a simple, passive device that is designed to surround a patient's failing heart, to geometrically remodel it and correct for the pathological increase in size that congestive heart failure causes.

You may also be interested in...



The Failing Heart

Looking for larger patient populations, the newer CHF device companies position their products as early intervention tools that can perhaps delay or halt the progression of the disease.

CardioEnergetics Inc.

David Melvin, MD, a cardiovascular surgeon turned biomedical engineer has created a large patent portfolio of cardiac devices and components covering novel solutions to sticky problems. CardioEnergetics was founded to commercialize his current and future inventions. The company's lead product is a ventricular assist device that lies outside the blood path to avoid clotting and stroke.

CardioEnergetics Inc.

David Melvin, MD, a cardiovascular surgeon turned biomedical engineer has created a large patent portfolio of cardiac devices and components covering novel solutions to sticky problems. CardioEnergetics was founded to commercialize his current and future inventions. The company's lead product is a ventricular assist device that lies outside the blood path to avoid clotting and stroke.

Topics

Related Companies

Related Deals

Latest News
See All
UsernamePublicRestriction

Register

MT037113

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel